Saturday , July 24 2021

Tag Archives: usfda full form

Lupin receives USFDA approval for Budesonide Inhalation Suspension

Lupin has received approval for its Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules from the United States Food and Drug Administration (USFDA) to market a generic version of AstraZeneca Pharmaceuticals LP’s (AstraZeneca) Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL. Lupin’s Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules is ... Read More »